Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

Post by bossuon Nov 21, 2022 3:31pm
134 Views
Post# 35116557

Revenues Y/Y

Revenues Y/Y

Just some numbers for Year 2022

                            Revenues   

2019                   32 752
2020                   29453
2021                   34464   17 % increase Y/Y

2022 9 months    26271
          Q4 2022    10 076 Same as Q 3 2021
 2022 total            36 347  5% increase Y/Y

What we need to have the same growth Y 2021 /Y 2022 or 17 %
or $ 40 326 000 

Most probably 2022 revenues have to be at minimun in between or at $ 38 000 M

Of course operation expenses are going to be higher than last year .burning rate higher and cash and cash equivalents at $ 18 M

Opsens have a great product and investtors will have to be patient for a minimum of 3 years but the best outcome would br a ''buyout''

Surely going to have some turbulence tomorrow and possibly  hair cut but cannot say how much .









<< Previous
Bullboard Posts
Next >>